AD 9308
Alternative Names: AD-9308Latest Information Update: 10 Nov 2023
At a glance
- Originator Foresee Pharmaceuticals
- Class Obesity therapies; Small molecules
- Mechanism of Action Aldehyde dehydrogenase 2 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Diabetes mellitus; Obesity